Skip to content
SHL Telemedicine
  • Home
  • About
    • SHL at a Glance
    • Mission
    • Client Portfolio
    • Partners
    • Leadership Team
  • Solutions & Products
    • Professionals
      • Solutions For CHF
      • Solution for COPD
      • Readmissions Solutions
      • Products
    • Consumers
      • Cardiac Monitoring Service
      • Personal Health Record
    • Telemedicine 24/7
  • Investors
    • Share Information
      • Share Price
      • Shareholder Structure
    • Newsroom
    • SEC Filings / Submissions
    • Annual Reports
      • Annual Reports
      • Key Figures
    • General Meeting
    • Corporate Governance
    • Event Calendar
    • IR Contact
  • Newsroom
  • Contact
  • Toggle website search
Press Escape to close the search panel.
  • Home
  • About
    • SHL at a Glance
    • Mission
    • Client Portfolio
    • Partners
    • Leadership Team
  • Solutions & Products
    • Professionals
      • Solutions For CHF
      • Solution for COPD
      • Readmissions Solutions
      • Products
    • Consumers
      • Cardiac Monitoring Service
      • Personal Health Record
    • Telemedicine 24/7
  • Investors
    • Share Information
      • Share Price
      • Shareholder Structure
    • Newsroom
    • SEC Filings / Submissions
    • Annual Reports
      • Annual Reports
      • Key Figures
    • General Meeting
    • Corporate Governance
    • Event Calendar
    • IR Contact
  • Newsroom
  • Contact
  • Toggle website search
Search this website

SHL Telemedicine’s Chairman intends to step down in the near term

For more information, please click here

Continue ReadingSHL Telemedicine’s Chairman intends to step down in the near term
  • Post published:August 2, 2024
  • Post category:

SHL Telemedicine to appoint David Arnon as CEO of SHL Telemedicine

For more information, please click here

Continue ReadingSHL Telemedicine to appoint David Arnon as CEO of SHL Telemedicine
  • Post published:July 29, 2024
  • Post category:

SHL Telemedicine confirms discussions regarding a possible investment in its Israeli activity

For more information, please click here

Continue ReadingSHL Telemedicine confirms discussions regarding a possible investment in its Israeli activity
  • Post published:June 20, 2024
  • Post category:

SHL Announces Full-Year 2023 Results – Stable Revenue Growth Alongside Groundbreaking Clinical Milestones

For more information, please click here

Continue ReadingSHL Announces Full-Year 2023 Results – Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
  • Post published:April 17, 2024
  • Post category:

SHL announces change in CEO position

For more information, please click here

Continue ReadingSHL announces change in CEO position
  • Post published:March 14, 2024
  • Post category:

Update regarding upcoming Annual General Meeting – Change in theComposition of the Board of Directors

For more information, please click here

Continue ReadingUpdate regarding upcoming Annual General Meeting – Change in theComposition of the Board of Directors
  • Post published:February 6, 2024
  • Post category:

SHL announces half-year results 2023

For more information, please click here

Continue ReadingSHL announces half-year results 2023
  • Post published:September 21, 2023
  • Post category:

SHL announces annual results 2022 – increase in revenues to USD 59.0m by 27% and take-off on all strategic fronts

For more information, please click here

Continue ReadingSHL announces annual results 2022 – increase in revenues to USD 59.0m by 27% and take-off on all strategic fronts
  • Post published:May 11, 2023
  • Post category:

SHL Telemedicine publishes its Annual Report on 11 May 2023

For more information, please click here

Continue ReadingSHL Telemedicine publishes its Annual Report on 11 May 2023
  • Post published:April 17, 2023
  • Post category:
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page

SHL HEADQUARTERS

  • Yigal Alon 90
    Tel Aviv, Israel 67891
  • +972-3-5612212

EUROPE

  • Balanstraße 69 b
    Munich, Germany, 81541
  • +49-89-48059-0

USA

  • 350 Motor Parkway, Suite 204
    Hauppauge, NY 11788
  • +1-877-777-9794

Subscribe for News and Updates


Loading

Accessibility Toolbar

  • Powered with favoriteLove by Codenroll